Tech Company Financing Transactions

Grid Therapeutics Funding Round

Grid Therapeutics secured a Series B financing round on 4/19/2018. Backers included Milestone Venture Partners and private investors.

Transaction Overview

Company Name
Grid Therapeutics
Announced On
4/19/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors

Milestone Venture Partners (Lead Investor)

private investors (Jeffery Heyman)

private investors (Paul Funk)

Proceeds Purpose
Grid will use the proceeds from the financing to accelerate and expand the development of Grid's lead therapeutic candidate, GT103, for the treatment of solid tumors, and to prepare for clinical trials in cancer patients scheduled to commence in early 2019.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Durham, NC 27517
USA
Phone
(919) 987-7190
Website
www.gridtherapeutics.com
Email Address
[email protected]
Overview
Grid Therapeutics is an emerging biotechnology company located in Durham, North Carolina. Grid's research and development efforts are in the area of cancer therapeutics, applying an innovative platform to develop human derived antibodies against novel targets.
Profile
Grid Therapeutics LinkedIn Company Profile
Social Media
Grid Therapeutics Company Twitter Account
Company News
Grid Therapeutics News
Facebook
Grid Therapeutics on Facebook
YouTube
Grid Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Edward Patz
  Edward Patz LinkedIn Profile  Edward Patz Twitter Account  Edward Patz News  Edward Patz on Facebook
Chief Operating Officer
Thomas Patz
  Thomas Patz LinkedIn Profile  Thomas Patz Twitter Account  Thomas Patz News  Thomas Patz on Facebook
VP - Bus. Development
Scott Lyman
  Scott Lyman LinkedIn Profile  Scott Lyman Twitter Account  Scott Lyman News  Scott Lyman on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/19/2018: ReviveMed venture capital transaction
Next: 4/19/2018: Wonolo venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.